Explore >> Select a destination

You are here

 news.mcmaster.ca
Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern - McMaster News
| | www.fda.gov
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants | FDA
6.5 parsecs away

Travel
| | The FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COV
| | rclutz.com
Hazardous Spike Proteins from mRNA Shots | Science Matters
7.3 parsecs away

Travel
| | Case Report Confirms mRNA Spike Proteins Found in the Heart and Brain of a Deceased Man - Spike Protein may have Contributed to the Patient's Lesions and Illness. Excerpts in italics with my bolds. Dr. Michael Mörz, who works at Hospital Dresden-Friedrichstadt in Germany, did a case report on a 76-year-old man with Parkinson's disease...
| | hub.jhu.edu
What will it take to develop a vaccine for COVID-19? | Hub
7.3 parsecs away

Travel
| | Global health expert Ruth Karron discusses the work currently taking place at laboratories around the country to develop a vaccine for COVID-19
| | miningawareness.wordpress.com
Russia's Sputnik V COVID Vaccine: the Danger of Journals Acting as Substitute Regulators; the Significant Risks Inadequately Tested Vaccines Present | Mining Awareness +
30.7 parsecs away

Travel
| While western mRNA and viral vector Covid vaccines received emergency approval with incomplete testing, Russia's Sputnik V viral vector vaccine was approved with almost no testing at all. To compare: The original Pfizer-BioNTech (mRNA) phase 1 and 2 trials were randomized with 7600 participants, and observer blind, as reported May 5, 2022: https://clinicaltrials.gov/ct2/history/NCT04368728?V_3=View#StudyPageTop Janssen (Johnson...